CSPC Pharmaceutical Group Statistics
Total Valuation
CSPCY has a market cap or net worth of 12.90 billion. The enterprise value is 11.94 billion.
| Market Cap | 12.90B |
| Enterprise Value | 11.94B |
Important Dates
The last earnings date was Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | Jun 5, 2025 |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -1.85% |
| Shares Change (QoQ) | -1.02% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 7.82B |
Valuation Ratios
The trailing PE ratio is 22.33 and the forward PE ratio is 17.87.
| PE Ratio | 22.33 |
| Forward PE | 17.87 |
| PS Ratio | 3.46 |
| PB Ratio | 2.77 |
| P/TBV Ratio | 3.17 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 20.67 |
| EV / Sales | 3.23 |
| EV / EBITDA | 14.36 |
| EV / EBIT | 18.23 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.08 |
| Debt / FCF | n/a |
| Interest Coverage | 109.38 |
Financial Efficiency
Return on equity (ROE) is 12.21% and return on invested capital (ROIC) is 8.64%.
| Return on Equity (ROE) | 12.21% |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 8.64% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 174,135 |
| Profits Per Employee | 27,002 |
| Employee Count | 21,400 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +18.63% in the last 52 weeks. The beta is 0.78, so CSPCY's price volatility has been lower than the market average.
| Beta (5Y) | 0.78 |
| 52-Week Price Change | +18.63% |
| 50-Day Moving Average | 3.01 |
| 200-Day Moving Average | 2.68 |
| Relative Strength Index (RSI) | 69.08 |
| Average Volume (20 Days) | 1,935 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSPCY had revenue of 3.73 billion and earned 577.85 million in profits. Earnings per share was 0.05.
| Revenue | 3.73B |
| Gross Profit | 2.55B |
| Operating Income | 667.88M |
| Pretax Income | 732.66M |
| Net Income | 577.85M |
| EBITDA | 823.15M |
| EBIT | 667.88M |
| Earnings Per Share (EPS) | 0.05 |
Balance Sheet
The company has 1.26 billion in cash and 69.91 million in debt, giving a net cash position of 1.19 billion.
| Cash & Cash Equivalents | 1.26B |
| Total Debt | 69.91M |
| Net Cash | 1.19B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 4.67B |
| Book Value Per Share | 0.39 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 68.45%, with operating and profit margins of 17.92% and 15.51%.
| Gross Margin | 68.45% |
| Operating Margin | 17.92% |
| Pretax Margin | 19.66% |
| Profit Margin | 15.51% |
| EBITDA Margin | 22.09% |
| EBIT Margin | 17.92% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.11, which amounts to a dividend yield of 2.58%.
| Dividend Per Share | 0.11 |
| Dividend Yield | 2.58% |
| Dividend Growth (YoY) | -6.63% |
| Years of Dividend Growth | 6 |
| Payout Ratio | n/a |
| Buyback Yield | 1.85% |
| Shareholder Yield | 4.43% |
| Earnings Yield | 4.48% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on November 16, 2020. It was a forward split with a ratio of 1.6.
| Last Split Date | Nov 16, 2020 |
| Split Type | Forward |
| Split Ratio | 1.6 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |